Conference icon

Conference

THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS

Publication status:
Published

Actions


Authors


Maughan, T More by this author
Seymour, M More by this author
Expand authors...
Volume:
21
Pages:
17-18
Publication date:
2010
ISSN:
0923-7534
URN:
uuid:60efec80-f2dd-447d-be50-92a04a155c6b
Source identifiers:
236547
Local pid:
pubs:236547

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP